Streetbeat News

Products Services

AAPL

Apple has launched the new iPhone 16 Pro MAX, featuring the best battery life among its predecessors and the new A18 PRO chip, which is more efficient than the A18.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:19 pm

TSLA

Tesla shares are rising as Panasonic prepares for mass production of high-capacity 4680 EV batteries, which could enhance Tesla's vehicle range and efficiency.

Portfolio Pulse from Dylan Berman

September 09, 2024 | 6:18 pm

EGIO

RLAY

SINT

U.S. stocks rose with the S&P 500 gaining around 1%. Relay Therapeutics shares spiked 63% after positive interim data for its breast cancer treatment. Sintx Technologies shares surged 87% following a patent allowance. Edgio shares dropped 80% due to financial restructuring.

Portfolio Pulse from Avi Kapoor

September 09, 2024 | 6:16 pm

AAPL

Apple has announced the new iPhone 16 Pro and iPhone 16 Pro MAX, featuring a new design with 6.3" and 6.9" displays, respectively. The phones are made with Grade 5 Titanium, making them more scratch-resistant and lighter, and are available in four colors.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:15 pm

AAPL

Apple has announced the new iPhone 16 priced at $799 and iPhone 16 Plus at $899, potentially impacting its stock price.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:12 pm

BA

GCAD

ITA

Boeing's shares rise following a tentative union deal to prevent a strike and the successful return of the Starliner. The deal includes a 25% wage increase and a commitment to build the next commercial airplane in Seattle. Analyst Ronald J. Epstein remains neutral pending the union vote.

Portfolio Pulse from Lekha Gupta

September 09, 2024 | 6:11 pm

MGNX

MacroGenics shares rise as the company announces it will present Phase 2 results from its TAMARACK trial on innovative cancer treatment at ESMO 2024.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:09 pm

AAPL

Apple has announced that its new A18 chip features a thermal design optimized for 30% higher sustained performance, particularly benefiting gaming applications.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:07 pm

EYEN

Eyenovia's stock is rising following the launch of a new FDA-approved ophthalmic drug in collaboration with Formosa Pharma.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 6:06 pm

AZN

ELVN

PFE

HC Wainwright initiated coverage on Enliven Therapeutics (NASDAQ:ELVN), highlighting its promising leukemia candidate ELVN-001, which could challenge existing treatments from Pfizer and AstraZeneca. The analyst gave a Buy rating with a $37 price target, noting potential peak sales of over $500 million.

Portfolio Pulse from Vandana Singh

September 09, 2024 | 6:05 pm